Aureum Diagnostics Limited

Aureum Diagnostics Limited is a private company based near Glasgow, Scotland, founded in February 2021. It specializes in designing, developing, and manufacturing high-performance, low-cost electrochemical biosensing platforms for point-of-care medical diagnostics and biosafety testing. The company’s core technology features a novel "sample to result" electrochemical sensing platform that combines a low-cost handheld instrument with single-use disposable test strips. This platform utilizes advanced electrochemical impedance spectroscopy (EIS) for the rapid and accurate detection of important medical molecules, including nucleic acids and proteins. Aureum Diagnostics focuses on addressing critical healthcare needs, such as the rapid diagnosis of COVID-19, sepsis, heart attacks, and various cancers. Aureum Diagnostics is committed to transforming global access to high-performance diagnostics while promoting sustainability. The company aims to make medical testing more affordable and accessible, collaborating with healthcare providers to enhance patient outcomes and public health.

• Employees 12
• Founded 2021